Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Dementia-Focused VC Fund Hopes To Succeed Where Other Research Strategies Have Not

This article was originally published in The Pink Sheet Daily

Executive Summary

A group of pharmaceutical companies, charities and the UK government are funding the first venture capital fund targeted against a specific condition, dementia.

You may also be interested in...



Alzheimer's Disease: Defusing The Bomb By 2025

The number of drug candidates in development for Alzheimer's is at its highest-ever level and despite the lack of success to date, biopharma companies continue to believe the potential rewards are worth the risk. As R&D in the field accelerates, therapies that treat not only symptoms of the disease but also slow its progression are expected to arrive sooner rather than later.

G8 Agrees World Will Tackle Alzheimer’s, But Solutions Are Some Way Off

The G8 dementia summit saw politicians, health stakeholders and financiers agree to target Alzheimer’s disease together, but a silver bullet may be years away.

UK Innovation Investment Fund: Are The Right Managers On The Job?

An effort to close the venture funding gap with the U.S. gets potential help in several ways.

Related Companies

Latest News
See All
UsernamePublicRestriction

Register

PS078269

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel